News
LexCase regularly publishes articles on the most relevant news, be it regulations, case law or various opinions.

Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA
14/04/2022
![[PUBLICATION] Lexology – Getting the Deal Through : « Healthcare Enforcement & Litigation »](https://lexcase.com/wp-content/uploads/2021/10/CABINET-365x120.jpg)
[PUBLICATION] Lexology – Getting the Deal Through : « Healthcare Enforcement & Litigation »
06/10/2021
![[INTERNSHIP OFFER] Immigration & international mobility](https://lexcase.com/wp-content/uploads/2019/07/we-are-hiring-2578901_960_720-365x120.jpg)
[INTERNSHIP OFFER] Immigration & international mobility
05/10/2021
![[PUBLIC LAW] The end of framework agreements without maximum](https://lexcase.com/wp-content/uploads/2021/09/Capture-decran-2021-09-09-a-09.45.05-365x120.png)
[PUBLIC LAW] The end of framework agreements without maximum
22/09/2021
![[IMMIGRATION] Covid-19: update of the conditions for entry into France Exemplaire](https://lexcase.com/wp-content/uploads/2021/09/image-breve-4-365x120.jpeg)
[IMMIGRATION] Covid-19: update of the conditions for entry into France Exemplaire
03/09/2021

Delphine Loyer joins LexCase as Partner, with Ferhat Oulbani
01/07/2021

Mathilde Merckx joins Lexcase as Of Counsel
22/06/2021

DOING BUSINESS IN FRANCE AFTER THE UK/EU TRADE AND COOPERATION AGREEMENT
08/02/2021
Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA

The LifeSciences team distinguished, once again, by The Legal 500 (Legalease) en TIER 2 en Industry Focus: Healthcare and LifeSciences.
Congratulations to the team and a huge thank you to our clients for their testimonials.
“The quality of the legal analysis, the availability of the team, the speed of execution, the pragmatic nature of the analyses, the command of English, the teamwork stand out.”
“Excellent knowledge of pharmaceutical regulations and regulatory subtleties. Excellent ability to advise by weighing the benefits and risks and being objective. Strength of proposal.”